Slashdot1 min read
Moderna Shares Plunge After Leak of Cancer Vaccine Data
Moderna shares plunged as much as 25% after partial clinical trial data leaked for its personalized cancer vaccine developed with Merck, despite the full results showing promising outcomes for melanoma patients.
By BeauHDSlashdot

Read the full story
Originally published by Slashdot on Oct 22, 2026.
Comments
Sign in to join the discussion.